Fusion PharmaceuticalsI Stock Forecast - Information Ratio
| FUSN Stock | USD 21.48 0.10 0.47% |
Fusion Stock Forecast is based on your current time horizon. Investors can use this forecasting interface to forecast Fusion PharmaceuticalsI stock prices and determine the direction of Fusion PharmaceuticalsInc's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of Fusion PharmaceuticalsI's historical fundamentals, such as revenue growth or operating cash flow patterns. Although Fusion PharmaceuticalsI's naive historical forecasting may sometimes provide an important future outlook for the firm, we recommend always cross-verifying it against solid analysis of Fusion PharmaceuticalsI's systematic risk associated with finding meaningful patterns of Fusion PharmaceuticalsI fundamentals over time.
Check out Historical Fundamental Analysis of Fusion PharmaceuticalsI to cross-verify your projections. Fusion |
Open Interest Against 2024-05-17 Fusion Option Contracts
Although open interest is a measure utilized in the options markets, it could be used to forecast Fusion PharmaceuticalsI's spot prices because the number of available contracts in the market changes daily, and new contracts can be created or liquidated at will. Since open interest in Fusion PharmaceuticalsI's options reflects these daily shifts, investors could use the patterns of these changes to develop long and short-term trading strategies for Fusion PharmaceuticalsI stock based on available contracts left at the end of a trading day.
Please note that to derive more accurate forecasting about market movement from the current Fusion PharmaceuticalsI's open interest, investors have to compare it to Fusion PharmaceuticalsI's spot prices. As Ford's stock price increases, high open interest indicates that money is entering the market, and the market is strongly bullish. Conversely, if the price of Fusion PharmaceuticalsI is decreasing and there is high open interest, that is a sign that the bearish trend will continue, and investors may react by taking short positions in Fusion. So, decreasing or low open interest during a bull market indicates that investors are becoming uncertain of the depth of the bullish trend, and a reversal in sentiment will likely follow.
Most investors in Fusion PharmaceuticalsI cannot accurately predict what will happen the next trading day because, historically, stock markets tend to be unpredictable and even illogical. Modeling turbulent structures requires applying different statistical methods, techniques, and algorithms to find hidden data structures or patterns within the Fusion PharmaceuticalsI's time series price data and predict how it will affect future prices. One of these methodologies is forecasting, which interprets Fusion PharmaceuticalsI's price structures and extracts relationships that further increase the generated results' accuracy.
| Check Fusion PharmaceuticalsI Volatility | Backtest Fusion PharmaceuticalsI | Information Ratio |
Fusion PharmaceuticalsI Trading Date Momentum
| On May 13 2024 Fusion PharmaceuticalsInc was traded for 21.48 at the closing time. The top price for the day was 21.50 and the lowest listed price was 21.35 . There was no trading activity during the period 0.0. Lack of trading volume on May 13, 2024 did not affect price variability. The overall trading delta against the current closing price is 0.37% . |
| Compare Fusion PharmaceuticalsI to competition |
Other Forecasting Options for Fusion PharmaceuticalsI
For every potential investor in Fusion, whether a beginner or expert, Fusion PharmaceuticalsI's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Fusion Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Fusion. Basic forecasting techniques help filter out the noise by identifying Fusion PharmaceuticalsI's price trends.Fusion PharmaceuticalsI Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Fusion PharmaceuticalsI stock to make a market-neutral strategy. Peer analysis of Fusion PharmaceuticalsI could also be used in its relative valuation, which is a method of valuing Fusion PharmaceuticalsI by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Fusion PharmaceuticalsInc Technical and Predictive Analytics
The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Fusion PharmaceuticalsI's price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Fusion PharmaceuticalsI's current price.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Fusion PharmaceuticalsI Market Strength Events
Market strength indicators help investors to evaluate how Fusion PharmaceuticalsI stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Fusion PharmaceuticalsI shares will generate the highest return on investment. By undertsting and applying Fusion PharmaceuticalsI stock market strength indicators, traders can identify Fusion PharmaceuticalsInc entry and exit signals to maximize returns.
Fusion PharmaceuticalsI Risk Indicators
The analysis of Fusion PharmaceuticalsI's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Fusion PharmaceuticalsI's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting fusion stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 3.85 | |||
| Semi Deviation | 1.92 | |||
| Standard Deviation | 12.55 | |||
| Variance | 157.62 | |||
| Downside Variance | 9.56 | |||
| Semi Variance | 3.7 | |||
| Expected Short fall | (4.89) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Historical Fundamental Analysis of Fusion PharmaceuticalsI to cross-verify your projections. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Complementary Tools for Fusion Stock analysis
When running Fusion PharmaceuticalsI's price analysis, check to measure Fusion PharmaceuticalsI's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Fusion PharmaceuticalsI is operating at the current time. Most of Fusion PharmaceuticalsI's value examination focuses on studying past and present price action to predict the probability of Fusion PharmaceuticalsI's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Fusion PharmaceuticalsI's price. Additionally, you may evaluate how the addition of Fusion PharmaceuticalsI to your portfolios can decrease your overall portfolio volatility.
| CEOs Directory Screen CEOs from public companies around the world | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency |
Is Fusion PharmaceuticalsI's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Fusion PharmaceuticalsI. If investors know Fusion will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Fusion PharmaceuticalsI listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.40) | Revenue Per Share 0.028 | Quarterly Revenue Growth (1.00) | Return On Assets (0.23) | Return On Equity (0.47) |
The market value of Fusion PharmaceuticalsInc is measured differently than its book value, which is the value of Fusion that is recorded on the company's balance sheet. Investors also form their own opinion of Fusion PharmaceuticalsI's value that differs from its market value or its book value, called intrinsic value, which is Fusion PharmaceuticalsI's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Fusion PharmaceuticalsI's market value can be influenced by many factors that don't directly affect Fusion PharmaceuticalsI's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Fusion PharmaceuticalsI's value and its price as these two are different measures arrived at by different means. Investors typically determine if Fusion PharmaceuticalsI is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Fusion PharmaceuticalsI's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.